[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU591683B2 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
AU591683B2
AU591683B2 AU58939/86A AU5893986A AU591683B2 AU 591683 B2 AU591683 B2 AU 591683B2 AU 58939/86 A AU58939/86 A AU 58939/86A AU 5893986 A AU5893986 A AU 5893986A AU 591683 B2 AU591683 B2 AU 591683B2
Authority
AU
Australia
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU58939/86A
Other languages
English (en)
Other versions
AU5893986A (en
Inventor
Wesley Dennis Miner
Gareth John Sanger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU5893986A publication Critical patent/AU5893986A/en
Application granted granted Critical
Publication of AU591683B2 publication Critical patent/AU591683B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU58939/86A 1985-06-22 1986-06-20 Novel treatment Ceased AU591683B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858515845A GB8515845D0 (en) 1985-06-22 1985-06-22 Treatment
GB8515845 1985-06-22

Publications (2)

Publication Number Publication Date
AU5893986A AU5893986A (en) 1986-12-24
AU591683B2 true AU591683B2 (en) 1989-12-14

Family

ID=10581184

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58939/86A Ceased AU591683B2 (en) 1985-06-22 1986-06-20 Novel treatment

Country Status (7)

Country Link
US (2) US4725603A (da)
EP (1) EP0215545A3 (da)
JP (1) JPS62424A (da)
AU (1) AU591683B2 (da)
DK (1) DK293086A (da)
GB (1) GB8515845D0 (da)
ZA (1) ZA864610B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8518658D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Medicaments
US5204356A (en) * 1985-07-24 1993-04-20 Glaxo Group Limited Treatment of anxiety
US4910193A (en) * 1985-12-16 1990-03-20 Sandoz Ltd. Treatment of gastrointestinal disorders
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
US4863919A (en) * 1988-02-01 1989-09-05 A. H. Robins Company, Incorporated Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
EP0353372B1 (en) * 1988-08-04 1993-02-03 Synthelabo Antischizophrenic-S-N-(1-azabicyclo[2.2.2.]oct-3-yl) benzamides and thiobenzamides
DE4012779C1 (da) * 1990-04-21 1991-05-02 Heidelberger Druckmaschinen Ag, 6900 Heidelberg, De
US5336169A (en) * 1993-03-02 1994-08-09 Divilio Robert J Attachment for removal of smoke in laparoscopic surgery
WO1998037068A1 (en) 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612319A (en) * 1982-04-14 1986-09-16 Beecham Group P.L.C. Bridged quinolizidinylbenzamides, compositions containing them and methods for their use
AU5657986A (en) * 1985-04-27 1986-11-06 F. Hoffmann-La Roche Ag Isoindole, Indazole and oxazole derivatives with azabicyclic substituents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56226B1 (en) * 1982-04-14 1991-05-22 Beecham Group Plc Substituted azabicyclo compounds,process for their preparation and pharmaceutical compositions containing them
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2557110B1 (fr) * 1983-12-23 1989-11-24 Sandoz Sa Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612319A (en) * 1982-04-14 1986-09-16 Beecham Group P.L.C. Bridged quinolizidinylbenzamides, compositions containing them and methods for their use
AU5657986A (en) * 1985-04-27 1986-11-06 F. Hoffmann-La Roche Ag Isoindole, Indazole and oxazole derivatives with azabicyclic substituents

Also Published As

Publication number Publication date
US4786643A (en) 1988-11-22
JPS62424A (ja) 1987-01-06
ZA864610B (en) 1987-06-24
AU5893986A (en) 1986-12-24
GB8515845D0 (en) 1985-07-24
DK293086D0 (da) 1986-06-20
DK293086A (da) 1986-12-23
US4725603A (en) 1988-02-16
EP0215545A3 (en) 1990-04-11
EP0215545A2 (en) 1987-03-25

Similar Documents

Publication Publication Date Title
AU590362B2 (en) Uv-dosimeter
AU5184886A (en) Somatostatines
AU569194B2 (en) 5-hydroxy-2-amino-pyrimidines
AU590605B2 (en) Gamma-carbolines
AU576731B2 (en) Undermattress
AU591903B2 (en) Novel treatment
AU586848B2 (en) Spiro-dioxolanes, - dithiolanes and-oxothiolanes
AU5313686A (en) Verktygsstal
AU5519386A (en) Epicondylitis-bandage
AU5514686A (en) Piperazinecarboxamides
AU5392186A (en) Picfilcylinder
AU581672B2 (en) Novel treatment
AU591683B2 (en) Novel treatment
ZA86433B (en) Novel treatment
AU584971B2 (en) Novel aminoalkylpyridineamides
AU586903B2 (en) 1-aryl-pyrazoles
AU8269787A (en) Flyslag treatment
AU563024B2 (en) Dihydropyridien
AU586307B2 (en) 1-aryl-pyrazoles
AU5352786A (en) Nasen-kapseln
AU5452286A (en) Wellenenergieanlage
AU4805485A (en) Schlauchbeutelpackung
AU5352386A (en) Vedenalainen tartuntamenetelma ja-valine
AU4544385A (en) Kubus-spielzeug
AU5805086A (en) N-phenyl-i-piperazine carboxamidines